loading…
J7187 Injection, von willebrand factor complex (humate-p), per iu vwf:rco
BackJ7030Infusion, normal saline solution , 1000 cc→J7040Infusion, normal saline solution, sterile (500 ml = 1 unit)→J70425% dextrose/normal saline (500 ml = 1 unit)→J7050Infusion, normal saline solution, 250 cc→J70605% dextrose/water (500 ml = 1 unit)→J7070Infusion, d5w, 1000 cc→J7100Infusion, dextran 40, 500 ml→J7110Infusion, dextran 75, 500 ml→J7120Ringers lactate infusion, up to 1000 cc→J71215% dextrose in lactated ringers infusion, up to 1000 cc→J7131Hypertonic saline solution, 1 ml→J7165Injection, prothrombin complex concentrate, human-lans, per i.u. of factor ix activity→J7168Prothrombin complex concentrate (human), kcentra, per i.u. of factor ix activity→J7169Injection, coagulation factor xa (recombinant), inactivated-zhzo (andexxa), 10 mg→J7170Injection, emicizumab-kxwh, 0.5 mg→J7171Injection, adamts13, recombinant-krhn, 10 iu→J7172Injection, marstacimab-hncq, 0.5 mg→J7173Injection, concizumab-mtci, 0.5 mg→J7174Injection, fitusiran, 0.04 mg→J7175Injection, factor x, (human), 1 i.u.→J7176Injection, human fibrinogen - chmt (fesilty), 1 mg→J7177Injection, human fibrinogen concentrate (fibryga), 1 mg→J7178Injection, human fibrinogen concentrate, not otherwise specified, 1 mg→J7179Injection, von willebrand factor (recombinant), (vonvendi), 1 i.u. vwf:rco→J7180Injection, factor xiii (antihemophilic factor, human), 1 i.u.→J7181Injection, factor xiii a-subunit, (recombinant), per iu→J7182Injection, factor viii, (antihemophilic factor, recombinant), (novoeight), per iu→J7183Injection, von willebrand factor complex (human), wilate, 1 i.u. vwf:rco→J7185Injection, factor viii (antihemophilic factor, recombinant) (xyntha), per i.u.→J7186Injection, antihemophilic factor viii/von willebrand factor complex (human), per factor viii i.u.→J7187Injection, von willebrand factor complex (humate-p), per iu vwf:rco→J7188Injection, factor viii (antihemophilic factor, recombinant), (obizur), per i.u.→J7189Factor viia (antihemophilic factor, recombinant), (novoseven rt), 1 microgram→J7190Factor viii (antihemophilic factor, human) per i.u.→J7191Factor viii (antihemophilic factor (porcine)), per i.u.→J7192Factor viii (antihemophilic factor, recombinant) per i.u., not otherwise specified→J7193Factor ix (antihemophilic factor, purified, non-recombinant) per i.u.→J7194Factor ix, complex, per i.u.→J7195Injection, factor ix (antihemophilic factor, recombinant) per iu, not otherwise specified→J7196Injection, antithrombin recombinant, 50 i.u.→J7197Antithrombin iii (human), per i.u.→J7198Anti-inhibitor, per i.u.→J7199Hemophilia clotting factor, not otherwise classified→J7200Injection, factor ix, (antihemophilic factor, recombinant), rixubis, per iu→J7201Injection, factor ix, fc fusion protein, (recombinant), alprolix, 1 i.u.→J7202Injection, factor ix, albumin fusion protein, (recombinant), idelvion, 1 i.u.→J7203Injection factor ix, (antihemophilic factor, recombinant), glycopegylated, (rebinyn), 1 iu→J7204Injection, factor viii, antihemophilic factor (recombinant), (esperoct), glycopegylated-exei, per iu→J7205Injection, factor viii fc fusion protein (recombinant), per iu→J7207Injection, factor viii, (antihemophilic factor, recombinant), pegylated, 1 i.u.→J7208Injection, factor viii, (antihemophilic factor, recombinant), pegylated-aucl, (jivi), 1 i.u.→J7209Injection, factor viii, (antihemophilic factor, recombinant), (nuwiq), 1 i.u.→J7210Injection, factor viii, (antihemophilic factor, recombinant), (afstyla), 1 i.u.→J7211Injection, factor viii, (antihemophilic factor, recombinant), (kovaltry), 1 i.u.→J7212Factor viia (antihemophilic factor, recombinant)-jncw (sevenfact), 1 microgram→J7213Injection, coagulation factor ix (recombinant), ixinity, 1 i.u.→J7214Injection, factor viii/von willebrand factor complex, recombinant (altuviiio), per factor viii i.u.→J7294Segesterone acetate and ethinyl estradiol 0.15mg, 0.013mg per 24 hours; yearly vaginal system, each→J7295Ethinyl estradiol and etonogestrel 0.015mg, 0.12mg per 24 hours; monthly vaginal ring, each→J7296Levonorgestrel-releasing intrauterine contraceptive system, (kyleena), 19.5 mg→J7297Levonorgestrel-releasing intrauterine contraceptive system (liletta), 52 mg→J7298Levonorgestrel-releasing intrauterine contraceptive system (mirena), 52 mg→J7299Intrauterine copper contraceptive (miudella)→J7300Intrauterine copper contraceptive (paragard)→J7301Levonorgestrel-releasing intrauterine contraceptive system (skyla), 13.5 mg→J7304Contraceptive supply, hormone containing patch, each→J7306Levonorgestrel (contraceptive) implant system, including implants and supplies→J7307Etonogestrel (contraceptive) implant system, including implant and supplies→J7308Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg)→J7311Injection, fluocinolone acetonide, intravitreal implant (retisert), 0.01 mg→J7312Injection, dexamethasone, intravitreal implant, 0.1 mg→J7313Injection, fluocinolone acetonide, intravitreal implant (iluvien), 0.01 mg→J7314Injection, fluocinolone acetonide, intravitreal implant (yutiq), 0.01 mg→J7315Mitomycin, ophthalmic, 0.2 mg→J7316Injection, ocriplasmin, 0.125 mg→J7318Hyaluronan or derivative, durolane, for intra-articular injection, 1 mg→J7320Hyaluronan or derivitive, genvisc 850, for intra-articular injection, 1 mg→J7321Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose→J7322Hyaluronan or derivative, hymovis or hymovis one, for intra-articular injection, 1 mg→J7323Hyaluronan or derivative, euflexxa, for intra-articular injection, per dose→J7324Hyaluronan or derivative, orthovisc, for intra-articular injection, per dose→J7325Hyaluronan or derivative, synvisc or synvisc-one, for intra-articular injection, 1 mg→J7326Hyaluronan or derivative, gel-one, for intra-articular injection, per dose→J7327Hyaluronan or derivative, monovisc, for intra-articular injection, per dose→J7328Hyaluronan or derivative, gelsyn-3, for intra-articular injection, 0.1 mg→J7329Hyaluronan or derivative, trivisc, for intra-articular injection, 1 mg→J7330Autologous cultured chondrocytes, implant→J7331Hyaluronan or derivative, synojoynt, for intra-articular injection, 1 mg→J7332Hyaluronan or derivative, triluron, for intra-articular injection, 1 mg→J7336Capsaicin 8% patch, per square centimeter→J7340Carbidopa 5 mg/levodopa 20 mg enteral suspension, 100 ml→J7342Instillation, ciprofloxacin otic suspension, 6 mg→J7345Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg→J7351Injection, bimatoprost, intracameral implant, 1 microgram→J7352Afamelanotide implant, 1 mg→J7353Anacaulase-bcdb, 8.8% gel, 1 gram→J7354Cantharidin for topical administration, 0.7%, single unit dose applicator (3.2 mg)→J7355Injection, travoprost, intracameral implant, 1 microgram→J7356Injection, foscarbidopa 0.25 mg/foslevodopa 5 mg→J7402Mometasone furoate sinus implant, (sinuva), 10 micrograms→J7500Azathioprine, oral, 50 mg→J7501Azathioprine, parenteral, 100 mg→J7502Cyclosporine, oral, 100 mg→J7503Tacrolimus, extended release, (envarsus xr), oral, 0.25 mg→J7504Lymphocyte immune globulin, antithymocyte globulin, equine, parenteral, 250 mg→J7507Tacrolimus, immediate release, oral, 1 mg→J7508Tacrolimus, extended release, (astagraf xl), oral, 0.1 mg→J7509Methylprednisolone oral, per 4 mg→J7510Prednisolone oral, per 5 mg→J7511Lymphocyte immune globulin, antithymocyte globulin, rabbit, parenteral, 25 mg→J7512Prednisone, immediate release or delayed release, oral, 1 mg→J7515Cyclosporine, oral, 25 mg→J7516Injection, cyclosporine, 250 mg→J7518Mycophenolic acid, oral, 180 mg→J7520Sirolimus, oral, 1 mg→J7521Tacrolimus, granules, oral suspension, 0.1 mg→J7524Mycophenolate mofetil, oral, 5 mg→J7525Tacrolimus, parenteral, 5 mg→J7526Injection, mycophenolate mofetil, 5 mg→J7527Everolimus, oral, 0.25 mg→J7529Mycophenolate mofetil, for suspension, oral, 5 mg→J7530Mycophenolate mofetil (myhibbin), oral suspension, 5 mg→J7531Prednisolone sodium phosphate, orally disintegrating tablet, 1 mg→J7599Immunosuppressive drug, not otherwise classified→J7601Ensifentrine, inhalation suspension, fda approved final product, non-compounded, administered through dme, unit dose form, 3 mg→J7604Acetylcysteine, inhalation solution, compounded product, administered through dme, unit dose form, per gram→J7605Arformoterol, inhalation solution, fda approved final product, non-compounded, administered through dme, unit dose form, 15 micrograms→J7606Formoterol fumarate, inhalation solution, fda approved final product, non-compounded, administered through dme, unit dose form, 20 micrograms→J7607Levalbuterol, inhalation solution, compounded product, administered through dme, concentrated form, 0.5 mg→J7608Acetylcysteine, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per gram→J7609Albuterol, inhalation solution, compounded product, administered through dme, unit dose, 1 mg→J7610Albuterol, inhalation solution, compounded product, administered through dme, concentrated form, 1 mg→J7611Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg→J7612Levalbuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 0.5 mg→J7613Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg→J7614Levalbuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 0.5 mg→J7615Levalbuterol, inhalation solution, compounded product, administered through dme, unit dose, 0.5 mg→J7620Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme→J7622Beclomethasone, inhalation solution, compounded product, administered through dme, unit dose form, per milligram→J7624Betamethasone, inhalation solution, compounded product, administered through dme, unit dose form, per milligram→J7626Budesonide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, up to 0.5 mg→J7627Budesonide, inhalation solution, compounded product, administered through dme, unit dose form, up to 0.5 mg→J7628Bitolterol mesylate, inhalation solution, compounded product, administered through dme, concentrated form, per milligram→J7629Bitolterol mesylate, inhalation solution, compounded product, administered through dme, unit dose form, per milligram→J7631Cromolyn sodium, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per 10 milligrams→J7632Cromolyn sodium, inhalation solution, compounded product, administered through dme, unit dose form, per 10 milligrams→J7633Budesonide, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, per 0.25 milligram→J7634Budesonide, inhalation solution, compounded product, administered through dme, concentrated form, per 0.25 milligram→J7635Atropine, inhalation solution, compounded product, administered through dme, concentrated form, per milligram→J7636Atropine, inhalation solution, compounded product, administered through dme, unit dose form, per milligram→J7637Dexamethasone, inhalation solution, compounded product, administered through dme, concentrated form, per milligram→J7638Dexamethasone, inhalation solution, compounded product, administered through dme, unit dose form, per milligram→J7639Dornase alfa, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram→J7640Formoterol, inhalation solution, compounded product, administered through dme, unit dose form, 12 micrograms→J7641Flunisolide, inhalation solution, compounded product, administered through dme, unit dose, per milligram→J7642Glycopyrrolate, inhalation solution, compounded product, administered through dme, concentrated form, per milligram→J7643Glycopyrrolate, inhalation solution, compounded product, administered through dme, unit dose form, per milligram→J7644Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram→J7645Ipratropium bromide, inhalation solution, compounded product, administered through dme, unit dose form, per milligram→J7647Isoetharine hcl, inhalation solution, compounded product, administered through dme, concentrated form, per milligram→J7648Isoetharine hcl, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, per milligram→J7649Isoetharine hcl, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram→J7650Isoetharine hcl, inhalation solution, compounded product, administered through dme, unit dose form, per milligram→J7657Isoproterenol hcl, inhalation solution, compounded product, administered through dme, concentrated form, per milligram→J7658Isoproterenol hcl, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, per milligram→J7659Isoproterenol hcl, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram→J7660Isoproterenol hcl, inhalation solution, compounded product, administered through dme, unit dose form, per milligram→J7665Mannitol, administered through an inhaler, 5 mg→J7667Metaproterenol sulfate, inhalation solution, compounded product, concentrated form, per 10 milligrams→J7668Metaproterenol sulfate, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, per 10 milligrams→J7669Metaproterenol sulfate, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per 10 milligrams→J7670Metaproterenol sulfate, inhalation solution, compounded product, administered through dme, unit dose form, per 10 milligrams→J7674Methacholine chloride administered as inhalation solution through a nebulizer, per 1 mg→J7676Pentamidine isethionate, inhalation solution, compounded product, administered through dme, unit dose form, per 300 mg→J7677Revefenacin inhalation solution, fda-approved final product, non-compounded, administered through dme, 1 microgram→J7680Terbutaline sulfate, inhalation solution, compounded product, administered through dme, concentrated form, per milligram→J7681Terbutaline sulfate, inhalation solution, compounded product, administered through dme, unit dose form, per milligram→J7682Tobramycin, inhalation solution, fda-approved final product, non-compounded, unit dose form, administered through dme, per 300 milligrams→J7683Triamcinolone, inhalation solution, compounded product, administered through dme, concentrated form, per milligram→J7684Triamcinolone, inhalation solution, compounded product, administered through dme, unit dose form, per milligram→J7685Tobramycin, inhalation solution, compounded product, administered through dme, unit dose form, per 300 milligrams→J7686Treprostinil, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, 1.74 mg→J7699Noc drugs, inhalation solution administered through dme→J7799Noc drugs, other than inhalation drugs, administered through dme→J7999Compounded drug, not otherwise classified→
Procedure codeCODABLE
J7187
Injection, von willebrand factor complex (humate-p), per iu vwf:rco
- Part
- HCPCS Level II
- J
- Drugs Administered Other than Oral Method
- J7
- J7030–J7999
Source
CMS — ICD-10-PCS FY2026, HCPCS Level II october 2026, Procedure Codes 2026.